Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Shanghai MicroPort MedBot Group
Watchlist
MicroPort MedBot Pre-IPO - Valuation Appears Reasonable but Sentiment Will Weigh
Equity Capital Markets
411 Views
21 Oct 2021 03:29
Shanghai MicroPort MedBot Group (MM), a surgical robot company, aims to raise up to US$200m in its Hong Kong IPO. Valuation appears reasonable but the deal has been downsized, a lot.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Japan
Equity Bottom-Up
Unpaywalled Insights
Sell / Short Ideas
Event-Driven
India
Index Rebalance
Asia Event-Driven
China
Macroeconomics
Trending Insights
More »
[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender - Surprising Results and Implications
Ryohin Keikaku (7453 JP): Global Index Inclusion Likely in August
Dickson Concepts (113 HK): Scheme Vote on 18 July for a Below Net Cash Offer
Vivendi: Mandatory Buyout in Motion – High-Conviction Risk Arb with 30%+ Upside
7&I (3382 JP) - Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
Top Unpaywalled Insights
More »
[IO Technicals 2025/29] Near Term Bullish Trend to Persist
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
MicroPort MedBot IPO Trading - Decent Demand But Upside Is Limited from the Top-End
01 Nov 2021
MicroPort MedBot Pre-IPO - Valuation Appears Reasonable but Sentiment Will Weigh
21 Oct 2021
MicroPort MedBot Pre-IPO - Thoughts on Valuation
04 Oct 2021
ECM Weekly (3rd October 2021) - MicroPort Medbot, MicroTech Med, Airdoc, Abbisko, FWD, PHC Hldgs
03 Oct 2021
MicroPort MedBot Pre-IPO - RoboDoc - PHIP Updates and a Look at Its Largest Competitor
30 Sep 2021
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x